Market research
BPX.F Bellicum Pharmaceuticals, Inc
F EUR Other
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 70M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the BPX.F discussion.
5 years, 5 months ago
Bellicum Pharmaceuticals, Inc is currently in a long term uptrend where the price is trading 3.5% above its 200 day moving average.
From a valuation standpoint, the stock is 66.1% cheaper than other stocks from the Other sector with a price to sales ratio of 4.3.
Based on the above factors, Bellicum Pharmaceuticals, Inc gets an overall score of 2/5.